Close Menu
Home » Sysmex Inostics, Merck Aim for 2015 CE Mark for ctDNA Kit for Metastatic Colorectal Cancer

Sysmex Inostics, Merck Aim for 2015 CE Mark for ctDNA Kit for Metastatic Colorectal Cancer

Jun 05, 2014
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) — In a deal signed ceremoniously at the American Society of Clinical Oncology meeting earlier this week in Chicago, Merck and Sysmex Inostics will collaborate to develop and commercialize a kit to assay RAS mutations in circulating tumor DNA. The kit will be based on Sysmex's emulsion-based digital PCR technology, called BEAMing. Terms of the agreement were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

PLOS Papers Look at Gut Mycobacterium Abscessus, Preterm Birth Transcriptomics, More

In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.

All That Plastic in the Lab

The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.

Garlic Helps, Too

People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.

Now Here

MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.

Nov
13
Featured Webinar

Targeted Detection of MET and NTRK Oncogenic Variants in Routine Molecular Analysis

Sponsored by
Agena Bioscience

This webinar will discuss advances in detecting MET and NTRK variants in tumor samples, which can help clinicians determine the appropriate therapy for cancer patients.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
04
Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

What's Popular?

In PCR

  1. 10x Genomics' Fully Automated Single-Cell Library Prep Platform Coming in Early 2020

    Premium

  2. ChromaCode Debuts Instrument-Agnostic Multiplex Panel for Multi-Drug Resistant Infection Screening

    Premium

  3. Bioneer Gets CE Mark for HCV Assay

  4. Merck, Promega Collaborate to Develop MSI CDx for Keytruda

  5. OraSure Strives for End-to-End Presence in Microbiome Market with Diversigen Buy

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.